Answers are grounded in this paper and cite their sources.
Case report reveals diabetic ketoacidosis in an infant, highlighting genetic mutation linked to treatment response.
Neonatal diabetes mellitus (NDM) is a rare monogenic disorder presenting usually within the first 6 months of life, with an estimated incidence ranging from 1 in 90,000 to 1 in 400,000 live births. We report a case of a 2-month-old male infant initially presenting with respiratory symptoms, later diagnosed with diabetic ketoacidosis. He was initially managed with intravenous insulin and subsequently transitioned to oral sulfonylurea. Genetic analysis revealed a heterozygous p.Gln1019Arg mutation in the ABCC8 gene, known to confer sulfonylurea responsiveness. The child demonstrated excellent clinical response to glibenclamide.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: